RBC's Biotechnology Research Team Initiates Coverage on 35 Companies

Published September 21, 2017
Mark Harris, Head of Global Research at RBC Capital Markets, talks to CNBC about initiating coverage on 35 biotechnology companies, as well as picks from the sector.

Mark Harris, Head of Global Research at RBC Capital Markets, talks to CNBC about initiating coverage on 35 biotechnology companies, as well as picks from the sector.

BiotechnologyTechnology Sector